Search Results

The AmeriWater MediQA Reverse Osmosis System is one component of a water treatment system designed to pre-treat and purify potable water using reverse osmosis for making dialysate for hemodialysis applications. The device is intended to be a component in a complete water purification system, and is not a complete water treatment system. It must be preceded by pre-treatment devices, and may need to be followed by post-treatment devices as well to meet current AAMI and Federal (U.S.) standards. The AmeriWater MediQA is intended for use in water rooms in a hospital, clinic, or dialysis center. The device includes an integrated heat sanitization process.

Reverse osmosis, the scientific concept used in the AmeriWater MEDIQA Reverse Osmosis System, is the opposite of osmosis. The MEDIQA system uses a pump to apply the pressure required for reverse osmosis. Potable tap water enters the MEDIQA through an inlet solenoid valve filling the feed water tank. A high pressure pump forces water from the feed tank through the RQ modules, each module containing a high performance membrane. The water entering the RO module is split into two flows. The water which passes through the membrane is known as permeate and is purified water. The water rejected by the membrane contains an increased level of dissolved contaminants. It passes out of the RO module as the second flow stream called concentrate, and is sent to drain.

The MEDIQA is available as a single pass or a double pass reverse osmosis (RO) unit. In a double pass (two RO stages) system, permeate from the first stage is pressurized by a second high pressure oump and fed to the second stage RO module set. Permeate from the second stage RO module set is fed via a manifold to the distribution loop. Unused permeate returning from the distribution loop is fed back into the feed tank. The concentrate from the first stage is sent to drain while the concentrate from the second stage is returned to the feed water tank for reprocessing. The feed and permeate water flows are monitored at various points in the process to verify temperature, conductivity, and flow. This data is displayed on a touch screen panel to give instant feedback of water quality and process activity. The MEDIQA system is controlled and operated by a touch screen mounted on the machine.

The AmeriWater MEDIQA Reverse Osmosis System also includes a built in heat sanitization feature to enable a heat sanitization of the reverse osmosis membranes and its pipe work. Heat sanitization can be activated manually using the HEATSAN buttons on the touch screen display or automatically if timer clock settings are implemented. The frequency of heat sanitization will depend upon usage and application demands. Monitoring of the system for bacterial content should be conducted at regular intervals to determine the optimum frequency for heat sanitization.

The provided text describes the AmeriWater MediQA Reverse Osmosis System, a water purification system for hemodialysis. The document is a 510(k) summary for premarket notification to the FDA.

Here's an analysis of the provided information, focusing on acceptance criteria and study details:

1. A table of acceptance criteria and the reported device performance

The document does not explicitly state "acceptance criteria" in a table format with specific quantifiable targets for the performance parameters. Instead, it describes the intended performance in comparison to standards and the predicate device.

However, based on the "Summary of Performance Testing" and the "Statement of Substantial Equivalence," we can infer the following performance goals and reported outcomes:

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not explicitly state the specific "sample size" for physical units of the device tested, nor does it detail the specific "country of origin of the data" or whether the studies were "retrospective or prospective."

It refers to "Non-clinical testing" and "Clinical studies."

• Non-clinical testing: This likely involved laboratory testing of the device performance, including the RO function and heat sanitization efficacy.
• Clinical studies: These "show evidence that the device, when used in accordance with the instructions for use, will produce water that meets current AAMI and Federal (U.S.) standards for hemodialysis." This suggests human use or simulation to verify the output water quality under real-world conditions, but no details on patient numbers or study design are provided.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not provided in the document. The document describes tests against established standards (AAMI and Federal (U.S.) standards for water quality) rather than relying on expert consensus for a ground truth in the typical sense of medical imaging or diagnostic studies. The evaluation of microbial reduction, for example, would likely follow standardized microbiology testing protocols.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable and not mentioned in the document. The device's performance is measured against objective physical, chemical, and microbiological standards, not subject to human interpretation requiring adjudication.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable and not mentioned. The device is a water purification system, not an AI-powered diagnostic or assistive tool for human readers.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is not applicable and not mentioned. The device performs a physical process (reverse osmosis and heat sanitization), and its performance is evaluated by measuring the quality of the water it produces, not by an algorithm's output.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The "ground truth" for the device's performance is defined by established regulatory and industry standards:

• Current AAMI (Association for the Advancement of Medical Instrumentation) standards for hemodialysis water quality.
• Federal (U.S.) standards for hemodialysis water quality.
• Microbiological testing protocols to determine bacterial reduction efficacy of heat sanitization.
• Biocompatibility, software validation, and electrical safety standards relevant to medical devices.

8. The sample size for the training set

This is not applicable and not mentioned. The AmeriWater MediQA Reverse Osmosis System is a physical medical device, not an AI/machine learning algorithm that requires a "training set."

9. How the ground truth for the training set was established

This is not applicable as there is no training set for this type of device.

Ask a specific question about this device